GSK adds to COPD pipeline as Exscientia deal bears fruit

GSK adds to COPD pipeline as Exscientia deal bears fruit

Source: 
Pharmaforum
snippet: 

AI drug research firm Exscientia has delivered the first candidate molecule to its partner GlaxoSmithKline following an R&D tie-up signed in 2017.